346 related articles for article (PubMed ID: 1903091)
1. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes.
Mikalsen A; Alexander J; Wallin H; Ingelman-Sundberg M; Andersen RA
Carcinogenesis; 1991 May; 12(5):825-31. PubMed ID: 1903091
[TBL] [Abstract][Full Text] [Related]
2. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
[TBL] [Abstract][Full Text] [Related]
3. Microsomal metabolism of hexavalent chromium. Inhibitory effect of oxygen and involvement of cytochrome P-450.
Mikalsen A; Alexander J; Ryberg D
Chem Biol Interact; 1989; 69(2-3):175-92. PubMed ID: 2495190
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome b(5) plays a key role in human microsomal chromium(VI) reduction.
Jannetto PJ; Antholine WE; Myers CR
Toxicology; 2001 Feb; 159(3):119-33. PubMed ID: 11223168
[TBL] [Abstract][Full Text] [Related]
5. Effect of in vivo chromate, acetone and combined treatment on rat liver in vitro microsomal chromium(VI) reductive activity and on cytochrome P450 expression.
Mikalsen A; Alexander J; Andersen RA; Ingelman-Sundberg M
Pharmacol Toxicol; 1991 Jun; 68(6):456-63. PubMed ID: 1716366
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of testosterone oxidation by purified rat cytochrome P450p (IIIA1).
Halvorson M; Greenway D; Eberhart D; Fitzgerald K; Parkinson A
Arch Biochem Biophys; 1990 Feb; 277(1):166-80. PubMed ID: 2106291
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P450.
Zbaida S; Levine WG
Biochem Pharmacol; 1990 Dec; 40(11):2415-23. PubMed ID: 2125221
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of monomeric reconstituted and membrane microsomal monooxygenase systems of the rabbit liver. II. Kinetic parameters of reductase and monooxygenase reactions.
Kanaeva IP; Nikityuk OV; Davydov DR; Dedinskii IR; Koen YM; Kuznetsova GP; Skotselyas ED; Bachmanova GI; Archakov AI
Arch Biochem Biophys; 1992 Nov; 298(2):403-12. PubMed ID: 1416971
[TBL] [Abstract][Full Text] [Related]
9. Reduction of hexavalent chromium in a reconstituted system of cytochrome P-450 and cytochrome b5.
Mikalsen A; Alexander J; Andersen RA; Daae HL
Chem Biol Interact; 1989; 71(2-3):213-21. PubMed ID: 2598298
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P-450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P-450-mediated reduction of oxygen and carbon tetrachloride.
Persson JO; Terelius Y; Ingelman-Sundberg M
Xenobiotica; 1990 Sep; 20(9):887-900. PubMed ID: 2122605
[TBL] [Abstract][Full Text] [Related]
11. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
12. Redox cycling of resorufin catalyzed by rat liver microsomal NADPH-cytochrome P450 reductase.
Dutton DR; Reed GA; Parkinson A
Arch Biochem Biophys; 1989 Feb; 268(2):605-16. PubMed ID: 2464338
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic reduction of chromium(VI) by human hepatic microsomes.
Pratt PF; Myers CR
Carcinogenesis; 1993 Oct; 14(10):2051-7. PubMed ID: 8222053
[TBL] [Abstract][Full Text] [Related]
14. Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450.
Dutton DR; Parkinson A
Arch Biochem Biophys; 1989 Feb; 268(2):617-29. PubMed ID: 2536534
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cytochrome P-450 reductase and reconstituted cytochrome P-450 mono-oxygenase system from rat brain. Evidence for constitutive presence in rat and human brain.
Anandatheerthavarada HK; Boyd MR; Ravindranath V
Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):483-8. PubMed ID: 1463452
[TBL] [Abstract][Full Text] [Related]
16. Isolation of cytochrome P450 from hepatopancreas microsomes of the spiny lobster, Panulirus argus, and determination of catalytic activity with NADPH cytochrome P450 reductase from vertebrate liver.
James MO
Arch Biochem Biophys; 1990 Oct; 282(1):8-17. PubMed ID: 2171437
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of the suicidal, reductive inactivation of microsomal cytochrome P-450 by carbon tetrachloride.
Manno M; De Matteis F; King LJ
Biochem Pharmacol; 1988 May; 37(10):1981-90. PubMed ID: 3377806
[TBL] [Abstract][Full Text] [Related]
18. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
Zhang Y; Guo X; Lin ET; Benet LZ
Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
[TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide.
Roberts ES; Hopkins NE; Alworth WL; Hollenberg PF
Chem Res Toxicol; 1993; 6(4):470-9. PubMed ID: 8374044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
